Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


4 Acta Obstet Gynecol Scand
2 Am J Obstet Gynecol
1 BMC Cancer
1 Cancer
1 Cancer Lett
1 Cancer Res
1 Clin Cancer Res
2 Eur J Obstet Gynecol Reprod Biol
2 Fertil Steril
4 Gynecol Endocrinol
3 Gynecol Oncol
1 Hum Pathol
2 Hum Reprod
1 Int J Cancer
11 Int J Gynaecol Obstet
2 Int J Radiat Oncol Biol Phys
1 J Clin Endocrinol Metab
2 J Clin Oncol
14 Obstet Gynecol
1 Oncogene
1 PLoS One
1 Pol J Radiol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Obstet Gynecol Scand

  1. GELDERBLOM ME, Jaspers V, Akkermans RP, Slangen B, et al
    First step in implementation of opportunistic salpingectomy for prevention of ovarian cancer: Current care and its determinants.
    Acta Obstet Gynecol Scand. 2023 Jan 20. doi: 10.1111/aogs.14507.
    PubMed         Abstract available

  2. SKYTTE HN, Christensen JJ, Gunnes N, Holven KB, et al
    Metabolic profiling of pregnancies complicated by preeclampsia: A longitudinal study.
    Acta Obstet Gynecol Scand. 2023 Jan 16. doi: 10.1111/aogs.14505.
    PubMed         Abstract available

  3. WIIK J, Vaernesbranden MR, Jonassen CM, Staff AC, et al
    Maternal human papillomavirus infection during pregnancy and preterm delivery, a mother-child cohort study in Norway and Sweden.
    Acta Obstet Gynecol Scand. 2023 Jan 16. doi: 10.1111/aogs.14509.
    PubMed         Abstract available

  4. KOTANIEMI-TALONEN L, Pukkala E, Aittomaki K, Auranen A, et al
    Long-term risk of cancer among the first-degree relatives of epithelial ovarian cancer patients: A cohort study with 48 years of follow up.
    Acta Obstet Gynecol Scand. 2023 Jan 16. doi: 10.1111/aogs.14504.
    PubMed         Abstract available

    Am J Obstet Gynecol

  5. SLADE L, Wilson M, Mistry HD, Bone JN, et al
    The 2017 American College of Cardiology/American Heart Association blood pressure categories in the second half of pregnancy - a systematic review of their association with adverse pregnancy outcomes.
    Am J Obstet Gynecol. 2023 Jan 16:S0002-9378(23)00017.
    PubMed         Abstract available

  6. LIU Y, Lan H
    Sacral Endometriosis.
    Am J Obstet Gynecol. 2023 Jan 11:S0002-9378(23)00012.

    BMC Cancer

  7. LI J, Li Y, Wang H, Shen L, et al
    Neoadjuvant chemotherapy with weekly cisplatin and paclitaxel followed by chemoradiation for locally advanced cervical cancer.
    BMC Cancer. 2023;23:51.
    PubMed         Abstract available


  8. AHMED A, Yang S
    Gestational age at birth and school performance.
    BMJ. 2023;380:p70.

  9. HUSBY A, Wohlfahrt J, Melbye M
    Gestational age at birth and cognitive outcomes in adolescence: population based full sibling cohort study.
    BMJ. 2023;380:e072779.
    PubMed         Abstract available


  10. BEN-ARYE E, Segev Y, Galil G, Marom I, et al
    Acupuncture during gynecological oncology surgery: A randomized controlled trial assessing the impact of integrative therapies on perioperative pain and anxiety.
    Cancer. 2023 Jan 17. doi: 10.1002/cncr.34542.
    PubMed         Abstract available

    Cancer Lett

  11. JIANG W, Ouyang X, Ji Z, Shi W, et al
    The PIK3CA-E545K-SIRT4 signaling axis reduces radiosensitivity by promoting glutamine metabolism in cervical cancer.
    Cancer Lett. 2023;556:216064.
    PubMed         Abstract available

    Cancer Res

  12. LLANO E, Todeschini AL, Felipe-Medina N, Corte-Torres MD, et al
    The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
    Cancer Res. 2023;83:239-250.
    PubMed         Abstract available

    Clin Cancer Res

  13. GREEN DS, Ning F, Duemler A, Myers TG, et al
    Correction: Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial.
    Clin Cancer Res. 2023;29:501.

    Eur J Obstet Gynecol Reprod Biol

  14. DI GIROLAMO R, Alameddine S, Khalil A, Santilli F, et al
    Clinical practice guidelines on the use of aspirin in pregnancy: Systematic review.
    Eur J Obstet Gynecol Reprod Biol. 2022;282:64-71.
    PubMed         Abstract available

  15. RALSER DJ, Condic M, Otten LA, Koensgen D, et al
    Evolving treatment landscape of advanced endometrial cancer - A current perspective from a German tertiary referral center for gynecological oncology.
    Eur J Obstet Gynecol Reprod Biol. 2023;282:61-63.

    Fertil Steril

  16. HESSAMI K, Khatibi A, Arian SE
    Response letter to "Endometrial Receptivity Array Before Frozen Embryo Transfer Cycles: A Systematic Review and Meta-analysis".
    Fertil Steril. 2023 Jan 12:S0015-0282(23)00046.

  17. TAGGAR A, Grow D
    We created the uterine imperfection, but when do we need to fix it?
    Fertil Steril. 2023 Jan 11:S0015-0282(23)00044.

    Gynecol Endocrinol

  18. ZHANG H, Chen Z, Wang X
    Differentiated serum levels of Kruppel-like factors 2 and 4, sP-selectin, and sE-selectin in patients with gestational diabetes mellitus.
    Gynecol Endocrinol. 2023 Jan 19:1-4. doi: 10.1080/09513590.2022.2164762.
    PubMed         Abstract available

  19. ZHENG R, Lin C, Mao Y, Jin F, et al
    miR-761-hepcidin/Gpx4 pathway contribute to unexplained liver dysfunction in polycystic ovary syndrome by regulating liver iron overload and ferroptosis.
    Gynecol Endocrinol. 2023 Jan 19:2166483. doi: 10.1080/09513590.2023.2166483.
    PubMed         Abstract available

  20. WANG W, Hao J, Shi Y
    IL23 suppresses proliferation and promotes apoptosis of human granulosa-like tumor cell line KGN by targeting the androgen receptor signal pathway.
    Gynecol Endocrinol. 2022;38:965-970.
    PubMed         Abstract available

  21. CAO LY, Zhang ZQ, Liu PP, Xu DF, et al
    Aberrant BMP15/HIF-1alpha/SCF signaling pathway in human granulosa cells is involved in the PCOS related abnormal follicular development.
    Gynecol Endocrinol. 2022;38:971-977.
    PubMed         Abstract available

    Gynecol Oncol

  22. SMITS A, Ten Eikelder M, Dhanis J, Moore W, et al
    Finding the sentinel lymph node in early cervical cancer: When is unusual not uncommon?
    Gynecol Oncol. 2023;170:84-92.
    PubMed         Abstract available

  23. ORELLANA TJ, Garrett AA, Soong TR, Rives T, et al
    The role of adjuvant treatment for early-stage uterine clear cell carcinomas.
    Gynecol Oncol. 2023;170:77-83.
    PubMed         Abstract available

  24. SHIRLEY J, Lambert P, Nachtigal MW, Altman AD, et al
    A comparison of synoptic reports and dictated reports to enhance and standardize surgical documentation and quality of care in epithelial ovarian cancer.
    Gynecol Oncol. 2023;170:54-58.
    PubMed         Abstract available

    Hum Pathol

  25. LU B, Xia Y, Chen J, Tang J, et al
    NCOA1/2/3 rearrangements in uterine tumor resembling ovarian sex cord tumor: a clinicopathological and molecular study of 18 cases.
    Hum Pathol. 2023 Jan 13:S0046-8177(23)00012.
    PubMed         Abstract available

    Hum Reprod

  26. TORRA-MASSANA M, Vassena R, Rodriguez A
    Sperm cryopreservation does not affect live birth rate in normozoospermic men: analysis of 7969 oocyte donation cycles.
    Hum Reprod. 2023 Jan 20:dead005. doi: 10.1093.
    PubMed         Abstract available

  27. MORAVEK MB, Dixon M, Pena SM, Obedin-Maliver J, et al
    Management of testosterone around ovarian stimulation in transmasculine patients: challenging common practices to meet patient needs-2 case reports.
    Hum Reprod. 2023 Jan 16:dead003. doi: 10.1093.
    PubMed         Abstract available

    Int J Cancer

  28. CASAS-AROZAMENA C, Moiola CP, Vilar A, Bouso M, et al
    Non-Invasive Detection of Microsatellite Instability in patients with Endometrial Cancer.
    Int J Cancer. 2023 Jan 17. doi: 10.1002/ijc.34435.
    PubMed         Abstract available

    Int J Gynaecol Obstet

  29. XIAO SY, Major CK, O'Connell KA, Lee D, et al
    Breast and Cervical Cancer Screening Rates in Student-Run Free Clinics: A Systematic Review.
    Int J Gynaecol Obstet. 2023 Jan 16. doi: 10.1002/ijgo.14675.
    PubMed         Abstract available

  30. SAKCAK B, Turgut E, Denizli R, Farisogullari N, et al
    Comparison of Serum Midkine Levels between Pregnant Women with and without Preeclampsia: A Case Control Study from a Tertiary Hospital.
    Int J Gynaecol Obstet. 2023 Jan 16. doi: 10.1002/ijgo.14677.
    PubMed         Abstract available

  31. CHEN L, Zhou W, Zhang Y, Zhao W, et al
    Natural evolution and risk factors for adverse outcome in selective intrauterine growth restriction under expectant management: A retrospective observational study.
    Int J Gynaecol Obstet. 2023 Jan 18. doi: 10.1002/ijgo.14679.
    PubMed         Abstract available

  32. WAINSTOCK T, Sergienko R, Orenshtein S, Sheiner E, et al
    Factors Associated With COVID-19 Vaccination Likelihood During Pregnancy.
    Int J Gynaecol Obstet. 2023 Jan 18. doi: 10.1002/ijgo.14680.
    PubMed         Abstract available

  33. LAW KS, Hsu YT, Chen HP
    Preliminary results of COVID-19 vaccination among Taiwanese pregnant women - a single-center, prospective, case-control study.
    Int J Gynaecol Obstet. 2023 Jan 18. doi: 10.1002/ijgo.14682.
    PubMed         Abstract available

  34. BHATLA N, Sehgal R, Konar H, Vivekanand A, et al
    A five-year comparative study of efficacy and acceptability of three different sizes of TCu380Ag and TCu380A intrauterine devices.
    Int J Gynaecol Obstet. 2023 Jan 18. doi: 10.1002/ijgo.14651.
    PubMed         Abstract available

  35. MONDAL R, Bhave P
    Accessory cavitated uterine malformation (ACUM): enhancing awareness about this unexplored perpetrator of dysmenorrhea.
    Int J Gynaecol Obstet. 2023 Jan 19. doi: 10.1002/ijgo.14681.
    PubMed         Abstract available

  36. YUE X, Yue Z, Wang Y, Dong Z, et al
    Value of the Copenhagen index in the diagnosis of malignant adnexal tumors: A meta-analysis.
    Int J Gynaecol Obstet. 2023;160:506-515.
    PubMed         Abstract available

  37. LEVIN G, Tsur A, Burke YZ, Meyer R, et al
    Methods of induction of labor after cesarean with no prior vaginal delivery-Perinatal outcomes.
    Int J Gynaecol Obstet. 2023;160:612-619.
    PubMed         Abstract available

  38. DING T, Li L, Duan R, Chen Y, et al
    Risk factors analysis of recurrent disease after treatment with a loop electrosurgical excision procedure for high-grade cervical intraepithelial neoplasia.
    Int J Gynaecol Obstet. 2023;160:538-547.
    PubMed         Abstract available

  39. SANDAK MD, Chandler KA, Goberdhan SP, Willett WF, et al
    Vulvar ductal carcinoma in situ as a manifestation of ectopic breast tissue.
    Int J Gynaecol Obstet. 2023;160:707-708.

    Int J Radiat Oncol Biol Phys

  40. ARIANS N, Lindel K, Krisam J, Oelmann-Avendano JT, et al
    Treatment tolerability and toxicity of postoperative proton beam therapy for gynecological malignancies - results of the prospective phase II APROVE-trial.
    Int J Radiat Oncol Biol Phys. 2023 Jan 12:S0360-3016(23)00012.
    PubMed         Abstract available

  41. VITTRUP AS, Kirchheiner K, Potter R, Fokdal LU, et al
    Overall severe morbidity after chemo-radiotherapy and MRI guided adaptive brachytherapy in locally advanced cervical cancer: results from the EMBRACE-I study.
    Int J Radiat Oncol Biol Phys. 2023 Jan 11:S0360-3016(23)00007.
    PubMed         Abstract available

    J Clin Endocrinol Metab

  42. ABBARA A, Phylactou M, Eng PC, Clarke SA, et al
    Endocrine responses to triptorelin in healthy women, women with Polycystic Ovary Syndrome and Hypothalamic Amenorrhea.
    J Clin Endocrinol Metab. 2023 Jan 19:dgad026. doi: 10.1210.
    PubMed         Abstract available

    J Clin Oncol

  43. DISILVESTRO P, Banerjee S, Colombo N, Scambia G, et al
    Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial.
    J Clin Oncol. 2022 Sep 9:JCO2201549. doi: 10.1200/JCO.22.01549.
    PubMed         Abstract available

  44. KONSTANTINOPOULOS PA, Lee EK, Xiong N, Krasner C, et al
    A Phase II, Two-Stage Study of Letrozole and Abemaciclib in Estrogen Receptor-Positive Recurrent Endometrial Cancer.
    J Clin Oncol. 2023;41:599-608.
    PubMed         Abstract available

    Obstet Gynecol

    Proliferative Endometrium in Menopause: To Treat or Not to Treat?
    Obstet Gynecol. 2023;141:265-267.

  46. O'BRIEN MS, Gupta A, Quevedo A, Lenger SM, et al
    Postoperative Complications of Appendectomy in Gynecologic Laparoscopic Surgery for Benign Indications.
    Obstet Gynecol. 2023;141:354-360.
    PubMed         Abstract available

  47. DESILETS J, Zakhari A, Chagnon M, Ekmekjian T, et al
    Pharmacologic Interventions to Minimize Fluid Absorption at the Time of Hysteroscopy: A Systematic Review and Meta-analysis.
    Obstet Gynecol. 2023;141:285-298.
    PubMed         Abstract available

  48. EMONT J, Wen T, Friedman AM, Wright JD, et al
    Trends in Hysterectomy Rates Associated With the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Obstet Gynecol. 2023 Jan 10. doi: 10.1097/AOG.0000000000005087.
    PubMed         Abstract available

  49. FUGARU I, Fogaing C, Aldhaheri S, Weibel H, et al
    Complex Gynecologic Fistulas Presenting 10 Years After Uterine Artery Embolization.
    Obstet Gynecol. 2023;141:375-378.
    PubMed         Abstract available

  50. SANTORO N, Flyckt R, Davis A, Finkelstein J, et al
    Anti-Mullerian Hormone Level Decline in Patients Undergoing Hysterectomy With and Without Oophorectomy Compared With Natural Menopause.
    Obstet Gynecol. 2023;141:331-340.
    PubMed         Abstract available

  51. MADISON AM, Powers D, Maslowsky J, Goyal V, et al
    Association Between Publicly Funded Contraceptive Services and the Abortion Rate in Texas, 2010-2015.
    Obstet Gynecol. 2023;141:361-370.
    PubMed         Abstract available

  52. LIAO L, Chen L, Melamed A, Hershman DL, et al
    Use of Conservative Therapies Before Hysterectomy for Uterine Leiomyomas.
    Obstet Gynecol. 2023;141:371-374.
    PubMed         Abstract available

  53. HAMEED AB, Haddock A, Wolfe DS, Florio K, et al
    Alliance for Innovation on Maternal Health: Consensus Bundle on Cardiac Conditions in Obstetric Care.
    Obstet Gynecol. 2023;141:253-263.
    PubMed         Abstract available

  54. SON M, Roy A, Grobman WA, Miller ES, et al
    Maximum Dose Rate of Intrapartum Oxytocin Infusion and Associated Obstetric and Perinatal Outcomes.
    Obstet Gynecol. 2023;141:379-386.
    PubMed         Abstract available

  55. JORGENSEN K, Meernik C, Wu CF, Murphy CC, et al
    Disparities in Fertility-Sparing Treatment and Use of Assisted Reproductive Technology After a Diagnosis of Cervical, Ovarian, or Endometrial Cancer.
    Obstet Gynecol. 2023;141:341-353.
    PubMed         Abstract available

  56. DARNEY BG, Boniface E, Liberty A
    Assessing the Effect of Abortion Restrictions: Improving Methodology and Expanding Outcomes.
    Obstet Gynecol. 2023;141:233-235.

  57. PRABHU M, Riley LE
    Coronavirus Disease 2019 (COVID-19) Vaccination in Pregnancy.
    Obstet Gynecol. 2023 Jan 17. doi: 10.1097/AOG.0000000000005100.
    PubMed         Abstract available

  58. CURLIN F
    Abortion as Essential Health Care and the Critical Role Your Practice Can Play in Protecting Abortion Access.
    Obstet Gynecol. 2023;141:419-420.


  59. ZHANG C, Jiang H, Yuan L, Liao Y, et al
    CircVPRBP inhibits nodal metastasis of cervical cancer by impeding RACK1 O-GlcNAcylation and stability.
    Oncogene. 2023 Jan 19. doi: 10.1038/s41388-023-02595.
    PubMed         Abstract available

    PLoS One

  60. FELEKE G, Tantu T, Zewdu D, Gedefawu A, et al
    Case-control study on determinants of uterine rupture among mothers who gave birth at Hawassa University comprehensive specialized hospital.
    PLoS One. 2023;18:e0279175.
    PubMed         Abstract available

    Pol J Radiol

  61. GHOSH A, Agnihotri T, Gupta V, Sitwala P, et al
    Transradial versus transfemoral arterial access in the uterine artery embolization of fibroids.
    Pol J Radiol. 2022;87:e672-e677.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Gynecology is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.